Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Anhydrous Sodium Citrate
2. Citra Ph
3. Monosodium Citrate
4. Sodium Citrate
5. Sodium Citrate Dihydrate
6. Sodium Citrate Monobasic
7. Sodium Citrate, Anhydrous
1. Sodium Citrate Dihydrate
2. 6132-04-3
3. Sodium Citrate Tribasic Dihydrate
4. Sodium Citrate Hydrate
5. 1,2,3-propanetricarboxylic Acid, 2-hydroxy-, Trisodium Salt, Dihydrate
6. Citric Acid Trisodium Salt Dihydrate
7. Trisodium;2-hydroxypropane-1,2,3-tricarboxylate;dihydrate
8. Mfcd00150031
9. Trisodium 2-hydroxypropane-1,2,3-tricarboxylate Dihydrate
10. Sodium Citrate, Dihydrate
11. B22547b95k
12. Citric Acid, Trisodium Salt, Dihydrate
13. Sodium Citrate Hydrous
14. Trisodium Citrate Dihydrate;citric Acid Trisodium Salt Dihydrate
15. Mfcd00130806
16. Tri-sodium Citrate Dihydrate
17. Sodium 2-hydroxypropane-1,2,3-tricarboxylate Dihydrate
18. Sodiumcitrate
19. N-1560
20. Natrum Citricum
21. Tricitrasol (tn)
22. Sodium Citrate (tn)
23. Sodium Citrate [usp:jan]
24. Sodiumcitratetribasicdihydrate
25. Sodium Citrate [fhfi]
26. Dtxsid1049437
27. Sodium Citrate Hydrate (jp17)
28. Unii-b22547b95k
29. Chebi:32142
30. Trisodium Citrate Dihydrate, Acs
31. Sodium Citrate Hydrous [ii]
32. Sodium Citrate Hydrate [jan]
33. Sodium Citrate [ep Monograph]
34. Sodium Citrate Dihydrate [mi]
35. Akos025293920
36. Citronensaeure,trinatrium-salz-dihydrat
37. Sodium Citrate Dihydrate, >=99%, Fg
38. Sodium Citrate Dihydrate [vandf]
39. Trisodium Citrate Dihydrate [ii]
40. Bp-31019
41. Sodium Citrate Dihydrate [who-dd]
42. Citrate, 0.5m Buffer Solution, Ph 3.0
43. Citrate, 0.5m Buffer Solution, Ph 4.0
44. Citrate, 0.5m Buffer Solution, Ph 4.5
45. Citrate, 0.5m Buffer Solution, Ph 5.0
46. Citrate, 0.5m Buffer Solution, Ph 5.5
47. Citrate, 0.5m Buffer Solution, Ph 6.0
48. Sodium Citrate Tribasic Dihydrate, >=98%
49. Sodium Citrate Dihydrate, Acs Reagent Grade
50. Sodium Citrate, Dihydrate [who-ip]
51. D01781
52. Sodium Citrate Tribasic Dihydrate, Ar, >=99%
53. Sodium Citrate Tribasic Dihydrate, Lr, >=99%
54. Citric Acid Trisodium Salt Dihydrate Acs Reagent
55. Natrii Citras, Dehydrate [who-ip Latin]
56. A833161
57. A835986
58. Trisodium Citrate Dihydrate [usp Monograph]
59. Q22075862
60. Sodium Citrate Dihydrate Biochemical Grade, Fine Granular
61. Sodium Citrate Tribasic Dihydrate, Usp, 99.0-100.5%
62. Sodium Citrate Tribasic Dihydrate (molecular Biology Grade)
63. Sodium Citrate Tribasic Dihydrate, Acs Reagent, >=99.0%
64. Trisodium 2-oxidanylpropane-1,2,3-tricarboxylate Dihydrate
65. Citric Acid Trisodium Salt Dihydratetrisodium Citrate Dihydrate
66. Sodium Citrate Tribasic Dihydrate, Bioultra, >=99.0% (nt)
67. Sodium Citrate Tribasic Dihydrate, Insect Cell Culture Tested
68. Sodium Citrate Tribasic Dihydrate, Jis Special Grade, >=99.0%
69. Sodium Citrate Tribasic Dihydrate, P.a., Acs Reagent, 99.0%
70. Sodium Citrate Tribasic Dihydrate, Purum P.a., >=99.0% (nt)
71. Sodium Citrate Tribasic Dihydrate, Saj First Grade, >=99.0%
72. Sodium Citrate Tribasic Dihydrate, Tested According To Ph.eur.
73. Trisodium 2-hydroxypropane-1,2,3-tricarboxylate--water (1/2)
74. Trisodium Citrate Dihydrate, Meets Usp Testing Specifications
75. 2-hydroxy-1,2,3-propanetricarboxylic Acid Trisodium Salt Dihydrate
76. Sodium Citrate Tribasic Dihydrate, Bioxtra, >=99.0% (titration)
77. Sodium Citrate Tribasic Dihydrate, For Molecular Biology, >=99%
78. Sodium Citrate Tribasic Dihydrate, Vetec(tm) Reagent Grade, 98%
79. Sodium Citrate, United States Pharmacopeia (usp) Reference Standard
80. 1,2,3-propanetricarboxylic Acid, 2-hydroxy-, Sodium Salt, Dihydrate
81. Sodium Citrate Tribasic Dihydrate, P.a., Acs Reagent, Reag. Iso, 99-101%
82. 1,2,3-propanetricarboxylic Acid, 2-hydroxy-, Sodium Salt, Hydrate (1:3:2)
83. Sodium Citrate Tribasic Dihydrate, Bioultra, For Molecular Biology, >=99.5% (nt)
84. Sodium Citrate Tribasic Dihydrate, Puriss. P.a., Acs Reagent, >=99.0% (nt)
85. Sodium Citrate Tribasic Dihydrate, Suitable For Amino Acid Analysis, >=99.0%
86. Sodium Citrate, Pharmaceutical Secondary Standard; Certified Reference Material
87. Sodium Citrate Tribasic Dihydrate, Puriss. P.a., Acs Reagent, Reag. Iso, Reag. Ph. Eur., >=99.5%
88. Sodium Citrate Tribasic Dihydrate, Puriss., Meets Analytical Specification Of Ph. Eur., Bp, Usp, Fcc, E331, 99-100.5% (calc. To The Dried Substance)
89. Sodium Citrate Tribasic Dihydrate, Suitable For Amino Acid Analysis, >=98% (titration), Powder
Molecular Weight | 294.10 g/mol |
---|---|
Molecular Formula | C6H9Na3O9 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 2 |
Exact Mass | 293.99396471 g/mol |
Monoisotopic Mass | 293.99396471 g/mol |
Topological Polar Surface Area | 143 Ų |
Heavy Atom Count | 18 |
Formal Charge | 0 |
Complexity | 211 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 6 |
Anticoagulants
Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)
Buffers
A chemical system that functions to control the levels of specific ions in solution. When the level of hydrogen ion in solution is controlled the system is called a pH buffer. (See all compounds classified as Buffers.)
Food Preservatives
Substances capable of inhibiting, retarding or arresting the process of fermentation, acidification or other deterioration of foods. (See all compounds classified as Food Preservatives.)
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-03-30
Pay. Date : 2016-11-01
DMF Number : 29906
Submission : 2015-12-07
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-04-02
Pay. Date : 2019-01-28
DMF Number : 32842
Submission : 2018-07-12
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11809
Submission : 1996-01-15
Status : Active
Type : II
Registration Number : 221MF10110
Registrant's Address : Hauptstrasse 2 D-31860 Emmerthal Germany
Initial Date of Registration : 2009-06-02
Latest Date of Registration : --
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
ABOUT THIS PAGE
A Trisodium Citrate Dihydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trisodium Citrate Dihydrate, including repackagers and relabelers. The FDA regulates Trisodium Citrate Dihydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trisodium Citrate Dihydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Trisodium Citrate Dihydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Trisodium Citrate Dihydrate supplier is an individual or a company that provides Trisodium Citrate Dihydrate active pharmaceutical ingredient (API) or Trisodium Citrate Dihydrate finished formulations upon request. The Trisodium Citrate Dihydrate suppliers may include Trisodium Citrate Dihydrate API manufacturers, exporters, distributors and traders.
click here to find a list of Trisodium Citrate Dihydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Trisodium Citrate Dihydrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Trisodium Citrate Dihydrate active pharmaceutical ingredient (API) in detail. Different forms of Trisodium Citrate Dihydrate DMFs exist exist since differing nations have different regulations, such as Trisodium Citrate Dihydrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Trisodium Citrate Dihydrate DMF submitted to regulatory agencies in the US is known as a USDMF. Trisodium Citrate Dihydrate USDMF includes data on Trisodium Citrate Dihydrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Trisodium Citrate Dihydrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Trisodium Citrate Dihydrate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Trisodium Citrate Dihydrate Drug Master File in Japan (Trisodium Citrate Dihydrate JDMF) empowers Trisodium Citrate Dihydrate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Trisodium Citrate Dihydrate JDMF during the approval evaluation for pharmaceutical products. At the time of Trisodium Citrate Dihydrate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Trisodium Citrate Dihydrate suppliers with JDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Trisodium Citrate Dihydrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Trisodium Citrate Dihydrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Trisodium Citrate Dihydrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Trisodium Citrate Dihydrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Trisodium Citrate Dihydrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Trisodium Citrate Dihydrate suppliers with NDC on PharmaCompass.
Trisodium Citrate Dihydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Trisodium Citrate Dihydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Trisodium Citrate Dihydrate GMP manufacturer or Trisodium Citrate Dihydrate GMP API supplier for your needs.
A Trisodium Citrate Dihydrate CoA (Certificate of Analysis) is a formal document that attests to Trisodium Citrate Dihydrate's compliance with Trisodium Citrate Dihydrate specifications and serves as a tool for batch-level quality control.
Trisodium Citrate Dihydrate CoA mostly includes findings from lab analyses of a specific batch. For each Trisodium Citrate Dihydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Trisodium Citrate Dihydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Trisodium Citrate Dihydrate EP), Trisodium Citrate Dihydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Trisodium Citrate Dihydrate USP).
LOOKING FOR A SUPPLIER?